EUVIMEDEUVIMED entdecken
Crossref

Thymol as Biofilm and Efflux Pump Inhibitor: A Dual‐Action Approach to Combat Mycobacterium tuberculosis

Bhabani Shankar Das, Ashirbad Sarangi, Isha Pahuja, Vishal Singh, Suvendu Ojha, Sidhartha Giri, Ashima Bhaskar, Debapriya Bhattacharya

Cell Biochemistry and Function · 2024

DOI: 10.1002/cbf.70030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Function, 2024. Verfasst von Bhabani Shankar Das und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India. Hauptthemen laut MEDLINE: Biofilms, Thymol, Mycobacterium tuberculosis, Microbial Sensitivity Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: This work was supported by the grant provided from DST-SERB, Government of India (SRG/2020/001922) and UGC, Government of India (UGC FD Diary No. 2183, 01-06-2…, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) remains a significant global health challenge, exacerbated by the emergence of drug‐resistant strains of Mycobacterium tuberculosis ( M. tb ). The complex biology of M. tb , particularly its key porins, contributes to its resilience against conventional treatments, highlighting the exploration of innovative therapeutic strategies. Following with this challenges, the present study investigates the bioactivity properties of phenolic compounds derived from the terpene groups, specifically through Thymol (THY) against M. smegmatis as a surrogated model fo r M. tb . Furthermore, the study employed with combination of two approaches i.e., in vitro assays and computational methods to evaluate the efficacy of THY against M. smegmatis and its interaction with M. tb biofilm and efflux pump proteins, particularly Rv1258c and Rv0194. The in vitro findings demonstrated that THY exhibits inhibitory activity against M. smegmatis and shows promising interaction with a combination of isoniazid (INH) and rifampicin (RIF) of TB regimens. Furthermore, THY demonstrated significant inhibitory action towards motility and biofilm formation of M. smegmatis . The combination of THY with INH and RIF exhibited a synergistic effect, enhancing the overall antimicrobial efficacy. Additionally, THY displayed reactive oxygen species (ROS) activity and potential efflux pump inhibitory action towards M. smegmatis . The computational analysis revealed that THY interacts effectively with efflux pump proteins Rv1258c and Rv0194, showing superior binding affinity compared to verapamil, a known efflux pump inhibitor. Pharmacokinetic studies highlighted that THY possess a favourable safety profile. In conclusion, THY represents a promising inhibitory compound for tuberculosis prevention, potentially addressing challenges posed by drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsThymolMycobacterium tuberculosisMicrobial Sensitivity TestsAntitubercular AgentsMycobacterium smegmatisMolecular Docking SimulationBacterial ProteinsRifampinReactive Oxygen SpeciesIsoniazidMembrane Transport Proteins

Stichwörter der Autor:innen

EPI activityROS activityanti‐biofilm activityanti‐sliding activitythymol

Substanzen

ThymolAntitubercular AgentsBacterial ProteinsRifampinReactive Oxygen SpeciesIsoniazidMembrane Transport Proteins

Autor:innen und Institutionen

  • Center for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India.
  • Immunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Department of infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, Odisha, India.
  • ICMR-Regional Medical Research Centre (RMRC), Bhubaneswar, Odisha, India.
  • Department of Biological Sciences, Indian Institute of Science Education and Research (IISER), Bhopal, Madhya Pradesh, India.

Förderung

  • This work was supported by the grant provided from DST-SERB, Government of India (SRG/2020/001922) and UGC, Government of India (UGC FD Diary No. 2183, 01-06-2…
  • Science and Engineering Research Board

Zitieren

APA

Shankar Das, B., Sarangi, A., Pahuja, I., Singh, V., Ojha, S., Giri, S., Bhaskar, A., & Bhattacharya, D. (2024). Thymol as Biofilm and Efflux Pump Inhibitor: A Dual‐Action Approach to Combat Mycobacterium tuberculosis. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70030

Vancouver

Shankar Das B, Sarangi A, Pahuja I, Singh V, Ojha S, Giri S, et al. Thymol as Biofilm and Efflux Pump Inhibitor: A Dual‐Action Approach to Combat Mycobacterium tuberculosis. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.70030

BibTeX
@article{ShankarDas2024,
  author = {Shankar Das, Bhabani and Sarangi, Ashirbad and Pahuja, Isha and Singh, Vishal and Ojha, Suvendu and Giri, Sidhartha and Bhaskar, Ashima and Bhattacharya, Debapriya},
  title = {Thymol as Biofilm and Efflux Pump Inhibitor: A Dual‐Action Approach to Combat Mycobacterium tuberculosis},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  doi = {10.1002/cbf.70030}
}
Kostenlos starten →